New Multiple Sclerosis Treatment Through Cellular Mechanism Discovery [VIDEO]
Researchers recently discovered a new cellular mechanism, located in the human brain, which is potentially the reason behind multiple sclerosis. Such discovery is being further exploited to be able to explain the cause of the autoimmune disease and potentially discover a new treatment for multiple sclerosis.
Human brain cells were extracted as test samples for the research. Upon careful observation, traces of the protein were observed in the MS diseased brain cells. This protein was found in the mitochondria, the powerhouse of the human cell. Scientists are now pointing out to the mitochondria, the powerhouse of the human cell, and the region that potentially possesses a link to multiple sclerosis, the Science Daily reports.
The study is the first attempt to combine clinical and laboratory experiments on understanding how the mitochondria malfunctions and how it can be prevented or treated to prevent MS. The research also managed to identify the protein (Rab32) and how it triggers such dangerous dysfunctions.
The massive number of this protein were observed inside the brain of MS patients. This results to miscommunications with the calcium supplies inside the mitochondria, causing it to behave unnaturally.
Healthy brain samples were observed to have no trace of the Rab32 protein. Although the research did not manage to explain why an unwelcome influx of Rab32 occurs but they manage to create a hypothesis that this originated at the base of the endoplasmic reticulum or the ER.
The ER is the portion of the mitochondria that stores calcium. With this recent discovery, a new treatment for multiple sclerosis can be exalted and be set to target the protein Rab32, the Medical Xpress revealed.
This recent discovery also gives hope to people around the world suffering from multiple sclerosis. At present, there is no significantly effective treatment that helps in reducing inflammation of the brain in MS patients. Controversial treatments such as vein-widening treatments are also partially effective and can pose unidentified risks in the future.